Five years of post-marketing liver safety data from the tolvaptan Risk Evaluation and Mitigation Strategy
托伐普坦风险评估和缓解策略的五年上市后肝脏安全性数据
期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfaf062
Lohrmann, Emanuel; Jaeger, Thomas; Enekebe, Kene; Zhang, Zhen; Wilt, Timothy; Riggen, Michele; Stemhagen, Annette; Nair, Indu; Nunna, Sasikiran; Fernandes, Ancilla W; Gandhi, Hema; Sergeyeva, Olga; George, Vinu